Zynerba Pharmaceuticals Announces Pricing of Its Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Zynerba Pharmaceuticals (ZYNE) IPO Opens Up 29% Higher
August 5, 2015 10:54 AM EDTToday's IPO for Zynerba Pharmaceuticals (NASDAQ: ZYNE) opened for trading at $18 after pricing 3 million shares of common stock at a public offering price of $14.00 per share, before underwriting discounts.
Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the... More
Zynerba Pharmaceuticals (ZYNE) Prices 3M Common Stock IPO at $14/Share
August 4, 2015 5:58 PM EDTZynerba Pharmaceuticals, Inc., (Nasdaq: ZYNE) announced today the pricing of its initial public offering of 3 million shares of common stock at a public offering price of $14.00 per share, before underwriting discounts. All of the shares in the offering are being sold by Zynerba. In... More
